Butedronic acid

DB16004InvestigationalSmall molecule

Butedronic acid is a radiopharmaceutical marked with technetium for bone scintigraphy. A medication used in combination with others for bone scans.

Chemical structure of Butedronic acid
Formula / weight
C5H10O10P2 · 292.073 g/mol (avg)

Resolves to

Compound
UNII26PB1U68YFCAS51395-42-7ChEMBLCHEMBL2106599ChEBI135216
Clinical / RWD
RxNorm1370573
Structure
InChIKeyLDTZSTJLVYBEKB-UHFFFAOYSA-NSMILESOC(=O)CC(C(P(O)(O)=O)P(O)(O)=O)C(O)=O

What you can answer from here — as of August 30, 2026

1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Butedronic acid, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In